A randomized placebo controlled pilot study to evaluate the efficacy of three month therapy of ubidecarenone in patients with cisplatin based regimen induced cachexia

ADITYA VIKRAM SINGH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年11月21日

研究概览

暂无简介。

•1. Patients of either gender with age equal to or more than 18 years 2. Patients with diagnosis of any stage of cancer and receiving cisplatin based regimen 3. Patients having the ability to understand and sign a written informed consent document

•1. Patient receiving concomitant medication(s) known to cause or aggravate cancer
•chemotherapy induced cachexia
•2. Patient receiving any other investigational agent
•3. Psychological or sociological conditions, addictive disorders, or family problems that would
•preclude adherence with study drug or compliance with the protocol
•4. Difficulty while swallowing oral medications due to prolonged emesis, mucositis, esophageal
•dysfunction, etc
•5. History of allergy to Ubidecarenone
•6. Patient with any infectious disease like TB, HIV-AIDS requiring pharmacotherapy
•7. Patient with history of uncontrolled co-morbid conditions like diabetes mellitus,
•hypertension, chronic kidney disease, autoimmune diseases like amyloidosis

发起方

ADITYA VIKRAM SINGH